US Stock MarketDetailed Quotes
HTGMQ HTG Molecular Diagnostics
- 0.000
- 0.0000.00%
15min DelayClose Aug 26 16:00 ET
442.85Market Cap0.00P/E (TTM)
0.000High0.000Low600Volume0.000Open0.000Pre Close0.12Turnover0.03%Turnover Ratio0.00P/E (Static)2.21MShares0.40052wk High0.00P/B441.65Float Cap0.00052wk Low--Dividend TTM2.21MShs Float3555.000Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low0.000Avg Price1Lot Size
HTG Molecular Diagnostics Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 26.53%-4.36M | -11.50%-18.41M | 40.32%-2.02M | -8.99%-4.6M | -28.59%-5.85M | -36.44%-5.94M | -1.33%-16.51M | 4.51%-3.39M | 3.26%-4.22M | -2.15%-4.55M |
| Net income from continuing operations | 22.20%-5.05M | -25.95%-21.59M | 9.61%-4.69M | -0.57%-4.52M | -125.17%-5.89M | -34.02%-6.5M | 17.85%-17.15M | -21.01%-5.19M | 17.02%-4.49M | 54.21%-2.61M |
| Operating gains losses | ---- | 93.32%-104K | --0 | ---100K | ---- | ---- | -347.95%-1.56M | -96.07%1.08K | --0 | -432.28%-1.74M |
| Depreciation and amortization | -53.58%86.1K | -18.59%587.14K | -34.57%100.02K | -30.67%133.85K | -5.42%167.78K | -6.29%185.49K | -46.44%721.25K | -50.14%152.87K | -43.17%193.05K | -49.56%177.38K |
| Other non cash items | 12.95%237.11K | -7.84%821.11K | 2.12%212.92K | -11.82%184.87K | 4.25%213.39K | -21.71%209.93K | -0.52%890.98K | -33.32%208.49K | -22.36%209.65K | 6.14%204.7K |
| Change In working capital | -8.62%-178.81K | 85.53%-143.19K | 22.43%1.19M | 4.22%-499.93K | 28.45%-667.89K | 67.45%-164.63K | -532.13%-989.75K | 355.02%971.37K | -2,822.01%-521.97K | -147.77%-933.41K |
| -Change in receivables | -78.43%289.72K | 183.25%670.77K | -121.51%-461.28K | 161.87%298.68K | -196.90%-509.87K | 2,256.70%1.34M | -151.14%-805.74K | 4.72%-208.25K | -34.57%-482.75K | -189.91%-171.73K |
| -Change in inventory | 104.59%5.51K | 110.31%140.83K | 168.62%324.36K | 179.80%48.79K | 84.33%-112.16K | -3.96%-120.16K | -431.40%-1.37M | -38,584.86%-472.73K | 54.76%-61.14K | -381.19%-715.93K |
| -Change in prepaid assets | 198.01%278.04K | -82.08%110.98K | -45.92%497.33K | -241.87%-387.46K | 46.39%-92.2K | 123.23%93.3K | 117.33%619.23K | 632.90%919.7K | -4.42%273.1K | -632.98%-171.97K |
| -Change in payables and accrued expense | 58.00%-597.44K | -161.79%-661.07K | -1.03%905.56K | -101.86%-345.4K | -61.11%201.25K | -642.17%-1.42M | 347.16%1.07M | 11.53%915K | -137.71%-171.11K | 182.48%517.55K |
| -Change in other current liabilities | -17.65%-116.25K | 10.67%-419.26K | -23.03%-111.92K | 6.15%-105.01K | 6.07%-103.52K | 36.76%-98.81K | 40.12%-469.33K | 54.49%-90.97K | 45.42%-111.89K | 42.78%-110.22K |
| -Change in other working capital | -195.32%-38.39K | 138.01%14.56K | 138.54%35.22K | -129.97%-9.54K | 81.72%-51.39K | -86.68%40.28K | 92.95%-38.31K | 85.00%-91.38K | 248.59%31.82K | -715.07%-281.12K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 26.53%-4.36M | -11.50%-18.41M | 40.32%-2.02M | -8.99%-4.6M | -28.59%-5.85M | -36.44%-5.94M | -1.33%-16.51M | 4.51%-3.39M | 3.26%-4.22M | -2.15%-4.55M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -165.74%-3.54M | 286.36%12.42M | 17.98%3.3M | 687.74%5.14M | 80.72%-1.41M | 293.62%5.39M | -135.58%-6.66M | -46.88%2.8M | 493.01%652.76K | -177.96%-7.33M |
| Net PPE purchase and sale | 25.87%-6.24K | 112.56%80.96K | 100.00%-1 | 126.35%92.04K | 98.14%-2.66K | 91.46%-8.42K | -42.07%-644.38K | -53.98%-53.65K | -262.53%-349.26K | 51.89%-142.97K |
| Net investment purchase and sale | -165.53%-3.54M | 304.96%12.34M | 15.76%3.3M | 403.98%5.05M | 80.37%-1.41M | 301.03%5.4M | -131.38%-6.02M | -46.22%2.85M | 385.44%1M | -174.09%-7.19M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -165.74%-3.54M | 286.36%12.42M | 17.98%3.3M | 687.74%5.14M | 80.72%-1.41M | 293.62%5.39M | -135.58%-6.66M | -46.88%2.8M | 493.01%652.76K | -177.96%-7.33M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -123.54%-1.31M | -17.19%8.6M | 23,054.95%7.7M | -1,485.05%-3.08M | -143.09%-1.58M | -14.73%5.57M | 14.83%10.39M | -101.88%-33.55K | -89.48%222.2K | 53.90%3.68M |
| Net issuance payments of debt | 35.22%-812.69K | -806.68%-6.95M | -400.81%-1.27M | -1,051.68%-2.91M | -1,623.85%-1.51M | -629.42%-1.25M | -214.88%-766.44K | 0.13%-254.04K | 0.26%-252.65K | -107.39%-87.74K |
| Net common stock issuance | ---- | --0 | --0 | --0 | ---- | ---- | 41.35%10.67M | --0 | --0 | 173.15%3.81M |
| Net preferred stock issuance | ---- | --1.19K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | -104.86%-350.52K | 7,111.69%9.1M | 2,715.33%2.04M | ---39.9K | -301.75%-107.81K | 2,210,789.26%7.21M | 73.42%126.15K | 356.93%72.39K | --0 | 112.62%53.44K |
| Net other financing activities | 62.03%-146.89K | 1,663.22%6.45M | 4,581.23%6.93M | -126.94%-127.91K | 136.03%36.36K | -148.02%-386.84K | 82.32%366.09K | -82.94%148.11K | 348.98%474.85K | 44.43%-100.9K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -123.54%-1.31M | -17.19%8.6M | 23,054.95%7.7M | -1,485.05%-3.08M | -143.09%-1.58M | -14.73%5.57M | 14.83%10.39M | -101.88%-33.55K | -89.48%222.2K | 53.90%3.68M |
| Net cash flow | ||||||||||
| Beginning cash position | 27.20%12.21M | -57.14%9.6M | -68.60%3.21M | -57.60%5.76M | -32.89%14.61M | -57.14%9.6M | 105.67%22.4M | -45.83%10.23M | -35.39%13.58M | 59.26%21.78M |
| Current changes in cash | -283.70%-9.22M | 120.48%2.62M | 1,533.21%8.98M | 24.25%-2.53M | -7.84%-8.85M | 922.10%5.02M | -211.26%-12.78M | -117.88%-626.36K | -56.48%-3.34M | -211.80%-8.2M |
| Effect of exchange rate changes | 208.43%3.87K | 60.74%-6.36K | 739.99%21.36K | -144.06%-13.14K | -585.36%-11.01K | 63.32%-3.57K | -182.54%-16.19K | -132.33%-3.34K | -198.28%-5.38K | -12.90%2.27K |
| End cash Position | -79.50%3M | 27.20%12.21M | 27.20%12.21M | -68.60%3.21M | -57.60%5.76M | -32.89%14.61M | -57.14%9.6M | -57.14%9.6M | -45.83%10.23M | -35.39%13.58M |
| Free cash flow | 26.53%-4.37M | -7.45%-18.43M | 41.25%-2.02M | -0.83%-4.6M | -24.82%-5.86M | -33.61%-5.95M | -2.43%-17.15M | 3.94%-3.44M | -2.49%-4.57M | 1.23%-4.69M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
